Robust evidence for bats as reservoir hosts is lacking in most African virus studies: a review and call to optimize sampling and conserve bats

N Weber, M Nagy, W Markotter, J Schaer… - Biology …, 2023 - royalsocietypublishing.org
Africa experiences frequent emerging disease outbreaks among humans, with bats often
proposed as zoonotic pathogen hosts. We comprehensively reviewed virus–bat findings …

Approaches and challenges to inferring the geographical source of infectious disease outbreaks using genomic data

Z Chen, P Lemey, H Yu - The Lancet Microbe, 2024 - thelancet.com
Genomic data hold increasing potential in the elucidation of transmission dynamics and
geographical sources of infectious disease outbreaks. Phylogeographic methods that use …

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks

AK Keita, FR Koundouno, M Faye, A Düx, J Hinzmann… - Nature, 2021 - nature.com
Seven years after the declaration of the first epidemic of Ebola virus disease in Guinea, the
country faced a new outbreak—between 14 February and 19 June 2021—near the …

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates

R Hunegnaw, AN Honko, L Wang, D Carr… - Science translational …, 2022 - science.org
Marburg virus (MARV) causes a severe hemorrhagic fever disease in primates with mortality
rates in humans of up to 90%. MARV has been identified as a category A bioterrorism agent …

National Monkeypox Surveillance, Central African Republic, 2001–2021

C Besombes, F Mbrenga, L Schaeffer… - Emerging infectious …, 2022 - pmc.ncbi.nlm.nih.gov
We analyzed monkeypox disease surveillance in Central African Republic (CAR) during
2001–2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as …

Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors

J Liu, JC Trefry, AM Babka, CW Schellhase… - Science translational …, 2022 - science.org
Effective therapeutics have been developed against acute Ebola virus disease (EVD) in both
humans and experimentally infected nonhuman primates. However, the risk of viral …

Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative …

S Meakin, J Nsio, A Camacho, R Kitenge… - The Lancet Infectious …, 2024 - thelancet.com
Background The recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV)
vaccine is the only WHO prequalified vaccine recommended for use to respond to outbreaks …

Chapare hemorrhagic fever and virus detection in rodents in Bolivia in 2019

R Loayza Mafayle, ME Morales-Betoulle… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background In June 2019, the Bolivian Ministry of Health reported a cluster of cases
of hemorrhagic fever that started in the municipality of Caranavi and expanded to La Paz …

The multiple origins of ebola disease outbreaks

SD Judson, VJ Munster - The Journal of Infectious Diseases, 2023 - academic.oup.com
Abstract Background The origins of Ebola disease outbreaks remain enigmatic. Historically
outbreaks have been attributed to spillover events from wildlife. However, recent data …

The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections

MR Hickman, DL Saunders, CA Bigger… - PLoS neglected …, 2022 - journals.plos.org
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear
Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure …